Cardiovascular & Metabolic Therapeutics
Scope: Includes drugs for hypertension, heart disease, diabetes, obesity, dyslipidaemia, and related metabolic conditions, while excluding implantable cardiac devices and biologic hormones.
This subcategory contains the following market intelligence reports: